Mustang Bio (MBIO) Return on Sales (2018 - 2019)
Mustang Bio (MBIO) posted quarterly Return on Sales of 7.94% for Q2 2019, down 123.0% year-over-year from 34.54% in Q2 2018, and down 16.37% quarter-over-quarter from 6.83% in Q3 2018.
Mustang Bio (MBIO) Return on Sales (2018 - 2019) Analysis & Trends
Mustang Bio (MBIO) has reported Return on Sales for 2 consecutive years, with 7.94% the latest figure, recorded in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Mustang Bio | 3.82 Mn | 3.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -7.94% |
| Sep 30, 2018 | -6.83% |
| Jun 30, 2018 | -6.71% |
| Mar 31, 2018 | -1.27% |